Literature DB >> 22170637

Plasmacytoid dendritic cells and Toll-like receptor 7-dependent signalling promote efficient protection of mice against highly virulent influenza A virus.

Michael M Kaminski1, Annette Ohnemus1, Marius Cornitescu1, Peter Staeheli1.   

Abstract

Types I and III interferons (IFNs) elicit protective antiviral immune responses during influenza virus infection. Although many cell types can synthesize IFN in response to virus infection, it remains unclear which IFN sources contribute to antiviral protection in vivo. We found that mice carrying functional alleles of the Mx1 influenza virus resistance gene partially lost resistance to infection with a highly pathogenic H7N7 influenza A virus strain if Toll-like receptor 7 (TLR7) signalling was compromised. This effect was achieved by deleting either the TLR7 gene or the gene encoding the TLR7 adaptor molecule MyD88. A similar decrease of influenza virus resistance was observed when animals were deprived of plasmacytoid dendritic cells (pDCs) at day 1 post-infection. Our results provide in vivo proof that pDCs contribute to the protection of the lung against influenza A virus infections, presumably via signals from TLR7.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22170637     DOI: 10.1099/vir.0.039065-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  22 in total

1.  MyD88-dependent immunity to a natural model of vaccinia virus infection does not involve Toll-like receptor 2.

Authors:  Michael L Davies; Janet J Sei; Nicholas A Siciliano; Ren-Huan Xu; Felicia Roscoe; Luis J Sigal; Laurence C Eisenlohr; Christopher C Norbury
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

2.  Mx1 reveals innate pathways to antiviral resistance and lethal influenza disease.

Authors:  Padmini S Pillai; Ryan D Molony; Kimberly Martinod; Huiping Dong; Iris K Pang; Michal C Tal; Angel G Solis; Piotr Bielecki; Subhasis Mohanty; Mark Trentalange; Robert J Homer; Richard A Flavell; Denisa D Wagner; Ruth R Montgomery; Albert C Shaw; Peter Staeheli; Akiko Iwasaki
Journal:  Science       Date:  2016-04-22       Impact factor: 47.728

Review 3.  Innate immunity to influenza virus infection.

Authors:  Akiko Iwasaki; Padmini S Pillai
Journal:  Nat Rev Immunol       Date:  2014-05       Impact factor: 53.106

4.  The role of MyD88 signaling in heterosubtypic influenza A virus infections.

Authors:  Rachel F Madera; Daniel H Libraty
Journal:  Virus Res       Date:  2012-12-10       Impact factor: 3.303

5.  Ketogenic diet activates protective γδ T cell responses against influenza virus infection.

Authors:  Emily L Goldberg; Ryan D Molony; Eriko Kudo; Sviatoslav Sidorov; Yong Kong; Vishwa Deep Dixit; Akiko Iwasaki
Journal:  Sci Immunol       Date:  2019-11-15

6.  Toll-like receptor 7 agonist imiquimod in combination with influenza vaccine expedites and augments humoral immune responses against influenza A(H1N1)pdm09 virus infection in BALB/c mice.

Authors:  Anna J X Zhang; Can Li; Kelvin K W To; Hou-Shun Zhu; Andrew C Y Lee; Chuan-Gen Li; Jasper F W Chan; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Vaccine Immunol       Date:  2014-02-12

Review 7.  Mammalian models for the study of H7 virus pathogenesis and transmission.

Authors:  Jessica A Belser; Terrence M Tumpey
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

8.  Efficient influenza A virus replication in the respiratory tract requires signals from TLR7 and RIG-I.

Authors:  Iris K Pang; Padmini S Pillai; Akiko Iwasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-05       Impact factor: 11.205

Review 9.  Host genetics of severe influenza: from mouse Mx1 to human IRF7.

Authors:  Michael J Ciancanelli; Laurent Abel; Shen-Ying Zhang; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2016-01-04       Impact factor: 7.486

10.  Visualizing the beta interferon response in mice during infection with influenza A viruses expressing or lacking nonstructural protein 1.

Authors:  Carsten Kallfass; Stefan Lienenklaus; Siegfried Weiss; Peter Staeheli
Journal:  J Virol       Date:  2013-04-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.